Cytori Therapeutics Garners $15,000,000 New Funding

  • Feed Type
  • Date
    10/15/2008
  • Company Name
    Cytori Therapeutics
  • Mailing Address
    3020 Callan Road San Diego, CA 92121
  • Company Description
    Cytori Therapeutics’ (Nasdaq: CYTX) goal is to be the global leader in regenerative medicine. Cytori is dedicated to providing patients with new options for reconstructive and aesthetic surgery, developing treatments for cardiovascular disease, and banking patients’ adipose-derived, adult stem and regenerative cells (ADRCs).
  • Website
    http://www.cytoritx.com
  • Transaction Type
    Debt
  • Transaction Amount
    $15,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The investment will be used to support the commercialization of Cytori’s recently launched Celution® System and StemSource® Cell Bank in Europe and Asia. In addition, the funds will support product pipeline development and general corporate activities. Securing this loan facility further demonstrates Cytori’s ability to attract funding from well regarded sources.
  • M&A Terms
  • Venture Investor
    GE Healthare Financial Services
  • Venture Investor
    Silicon Valley Bank

By posting a comment, you agree to our terms and conditions.